Basho Chandan 4

What Happened

• Basho Chandan, Astrana Health’s Chief Operating Officer and Chief Financial Officer, surrendered 3,870 shares on April 14, 2026 to satisfy tax withholding obligations tied to restricted stock that vested that day. The shares were valued at $29.07 each, for a total of $112,501. This was a tax-withholding disposition (code F), not an open-market sale.

Key Details

• Transaction date and price: April 14, 2026; 3,870 shares at $29.07 per share (total ~$112,501).
• Transaction type: F — shares surrendered to cover tax withholding on vested restricted stock (routine settlement).
• Ownership details disclosed in the filing (footnote): includes 30,404 shares of unvested restricted stock (to vest in two equal annual installments on May 16, 2026 and May 16, 2027) and restricted stock units totaling 35,631 (15,604 RSUs vesting in four equal semi-annual installments beginning Oct 2, 2026; 20,027 RSUs vesting in six equal semi-annual installments beginning Sep 5, 2026). All vesting is subject to continued employment.
• Filing timing: Reported on Form 4 with period of report 2026-04-14 and filed 2026-04-15 (timely).

Context

• This is a routine tax-withholding action associated with vesting of restricted stock, not a discretionary sale that signals a change in sentiment. Such “surrender-to-cover” transactions are common when equity awards vest and companies or insiders satisfy tax liabilities by withholding or surrendering shares.